Shaker M - Search Results

1

Information needs of patients considering oral immunotherapy for food allergy.

Mack DP, Greenhawt M, Turner PJ, Wasserman RL, Hanna MA, Shaker M, Hughes SW, Del Río PR. Mack DP, et al. Among authors: shaker m. Clin Exp Allergy. 2022 Dec;52(12):1391-1402. doi: 10.1111/cea.14225. Epub 2022 Sep 21. Clin Exp Allergy. 2022. PMID: 36083693 Review.

2

An update on ocular allergy.

Shaker M, Salcone E. Shaker M, et al. Curr Opin Allergy Clin Immunol. 2016 Oct;16(5):505-10. doi: 10.1097/ACI.0000000000000299. Curr Opin Allergy Clin Immunol. 2016. PMID: 27490123 Review.

3

Caregiver and expecting caregiver support for early peanut introduction guidelines.

Greenhawt M, Chan ES, Fleischer DM, Hicks A, Wilson R, Shaker M, Venter C, Stukus D. Greenhawt M, et al. Among authors: shaker m. Ann Allergy Asthma Immunol. 2018 Jun;120(6):620-625. doi: 10.1016/j.anai.2018.03.001. Epub 2018 Mar 7. Ann Allergy Asthma Immunol. 2018. PMID: 29524559

4

Summary and simulation of reported adverse events from epinephrine autoinjectors and a review of the literature.

Shaker M, Toy D, Lindholm C, Low J, Reigh E, Greenhawt M. Shaker M, et al. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2143-2145.e4. doi: 10.1016/j.jaip.2018.04.006. Epub 2018 Apr 13. J Allergy Clin Immunol Pract. 2018. PMID: 29660429 Review. No abstract available.

5

The Health and Economic Outcomes of Peanut Allergy Management Practices.

Shaker M, Greenhawt M. Shaker M, et al. J Allergy Clin Immunol Pract. 2018 Nov-Dec;6(6):2073-2080. doi: 10.1016/j.jaip.2018.04.036. Epub 2018 May 8. J Allergy Clin Immunol Pract. 2018. PMID: 29751153

6

An economic evaluation of immediate vs non-immediate activation of emergency medical services after epinephrine use for peanut-induced anaphylaxis.

Shaker M, Kanaoka T, Feenan L, Greenhawt M. Shaker M, et al. Ann Allergy Asthma Immunol. 2019 Jan;122(1):79-85. doi: 10.1016/j.anai.2018.06.035. Epub 2018 Jul 17. Ann Allergy Asthma Immunol. 2019. PMID: 30025910

7

The health and economic outcomes of early egg introduction strategies.

Shaker M, Verma K, Greenhawt M. Shaker M, et al. Allergy. 2018 Nov;73(11):2214-2223. doi: 10.1111/all.13565. Allergy. 2018. PMID: 30028905

8

Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis.

Shaker M, Greenhawt M. Shaker M, et al. JAMA Netw Open. 2018 Nov 2;1(7):e184728. doi: 10.1001/jamanetworkopen.2018.4728. JAMA Netw Open. 2018. PMID: 30646369 Free PMC article.

9

Estimation of Health and Economic Benefits of Commercial Peanut Immunotherapy Products: A Cost-effectiveness Analysis.

Shaker M, Greenhawt M. Shaker M, et al. JAMA Netw Open. 2019 May 3;2(5):e193242. doi: 10.1001/jamanetworkopen.2019.3242. JAMA Netw Open. 2019. PMID: 31050778 Free PMC article.

10

An update on allergic emergencies.

Toy D, Braga MS, Greenhawt M, Shaker M. Toy D, et al. Among authors: shaker m. Curr Opin Pediatr. 2019 Jun;31(3):426-432. doi: 10.1097/MOP.0000000000000769. Curr Opin Pediatr. 2019. PMID: 31090587 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters